期刊文献+

强化胰岛素治疗对严重创伤患者淋巴细胞亚群水平及预后的影响

Effects of intensive insulin therapy on peripheral T-lymphocyte subpopulations and prognosis in patients with severe trauma
下载PDF
导出
摘要 目的探讨强化胰岛素治疗对严重创伤患者淋巴细胞亚群动态变化和对预后的影响。方法对收治的56例严重创伤患者随机分为强化胰岛素治疗组(A组,控制血糖在4.4~6.1mmol/L)和常规治疗组(B组,控制血糖在10.0~11.1mmol/L),观察两组患者治疗前后外周血淋巴细胞亚群水平以及并发症发生率和死亡率。结果 A组与B组比较,外周血CD3+、CD4+、CD4+/CD8+比值治疗第1、3天水平较低,第1天两组比较,差异均无统计学意义(t分别=1.14、0.74、0.60,P均>0.05),治疗后逐渐开始升高。两组患者于治疗第3、7、14天,A组CD3+、CD4+、CD4+/CD8+比值大于B组,上升速度快于B组,两组比较,差异均有统计学意义(t分别=2.69、3.31、2.37;2.73、3.93、4.27;3.40、5.71、10.68,P均<0.05)。两组各时段的CD8+比较,除第3天差异有统计学意义外(t=2.31,P<0.05),其余时段比较,差异均无统计学意义(t分别=1.24、0.95、0.48,P均>0.05)。A组合计并发症发生率和病死率均低于B组,差异均有统计学意义(χ2分别=5.91、4.88,P均<0.05)。结论强化胰岛素治疗严重创伤患者可降低并发症发生率和死亡率;同时淋巴细胞亚群水平检测可以作为其治疗过程中疾病严重程度及预后的指标。 Objective To investigate the influence of the alteration of intensive insulin therapy(IIT) on serum peripheral T-lymphocyte subpopulations and prognosis in patients with severe trauma.Methods A total of 56 patients with severe trauma were randomly divided into 2 groups.Intensive insulin therapy group was treated with tight control of blood glucose by intensive insulin therapy(group A,maintenance of blood glucose at a level between 4.4 and 6.1 mmol/L),and the other one was treated with conventional treatment(group B,maintenance of blood glucose at a level between 10.0 and 11.1 mmol/L).Serum peripheral T-lymphocyte subpopulations were measured before and after therapy in each group.The incidence rate of complication and mortality were recorded.Results There was no significant difference in the ratios of CD3+,CD4+,CD4+/CD8+ between group A and group B on day 1(t=1.14,0.74,0.60,P0.05).The ratios of the peripheral T-lymphocyte subpopulations were low on day 1 and day 3,then were elevated after treatment in two groups.The ratios and the rate of ascend of CD3+,CD4+,CD4+/CD8+ in group A were higher and faster than that in group B on day 3,7,14(t=2.69,3.31,2.37;2.73,3.93,4.27;3.40,5.71,10.68,P0.05).There was no significant difference in the ratios of CD8+ between two groups on day 1,7,14(t=1.24,0.95,0.48,P0.05),except on day 3(t=2.31,P0.05).There was significant different in the incidence rate of complication and mortality between group A and B(χ2=5.91,4.88,P0.05).Conclusions Tight control of blood glucose by IIT can reduce the incidence rate of complication and mortality in severe traumatic patients;besides,T-lymphocyte subpopulations can be used as the indicators of the severity and prognosis.
出处 《全科医学临床与教育》 2011年第5期502-504,519,共4页 Clinical Education of General Practice
关键词 强化胰岛素治疗 严重创伤 淋巴细胞亚群 intensive insulin therapy severe trauma T-lymphocyte subpopulations
  • 相关文献

参考文献9

  • 1崔岩.长期经济停滞条件下的日本劳动市场:以失业率为中心的分析[J].世界经济,2002,25(4):60-63. 被引量:6
  • 2美国机动车医学促进会.重庆市急救医疗中心编译.简明损伤定级标准2005[M].重庆:重庆出版社,2005.1-35.
  • 3Berghe G,Wouters P,Weekers F,et al.Intensive insulin therapy in critically ill[J].N Eng J Med,2001,345(19):1359-1367.
  • 4董月青,姚咏明.脓毒症中细胞免疫紊乱的机制[J].中国危重病急救医学,2004,16(10):636-638. 被引量:50
  • 5Das UN.Insulin and the critically ill[J].Crit Care Med,2002,6(3):262-263.
  • 6Spielmann S,Kemer T,Ahlers O,et al.Early detection of increased tumor necrosis factor alpha(TNF-)and soluble TNF receptor protein plasma levels aftert trauma reveals associations with the clinical course[J].Acta Anaesthesiol Scand,2001,45(5):364-370.
  • 7Berghe G,Wouters PJ,Bouillon R,et al.Outcome benefit of intensive insulin therapy in the critically ill:insulin dose versus glycemic control[J].Crit Care Med,2003,31(2):359-366.
  • 8Hirsch IB,Coviello A,Mazuski J,et al.Intensive insulin therapy in critically ill patients[J].N Engl J Med,2002,346(9):1586-1588.
  • 9王正国.创伤基础研究进展[J].中华创伤杂志,2005,21(1):6-10. 被引量:34

二级参考文献74

  • 1李继峰,艾峋,俞彰,顾玉东,袁伟,袁琦梅.聚酸酐管桥接修复神经缺损和聚酸酐管降解时相研究[J].复旦学报(医学版),2003,30(3):229-231. 被引量:2
  • 2[美]萨缪尔森 诺德豪斯.《经济学》上册[M].中国发展出版社,1992..
  • 3[日]小野旭.《日本的劳动市场--外部市场的机能和构造》[M].东洋经济新报社,1981..
  • 4[英]凯恩斯.《就业、利息和货币通论》[M].商务印书馆,1999..
  • 5Barth E,Fischer G,Schneider E M,et al.Differences in the expression of CD64 and CD14 (mCD14) on polymorphonuclear cells and on monocytes in patients with septic shock [J]. Cytokine, 2001,14: 299 -302.
  • 6Saccani S, Saccani S, Varesio, et al.Divergent effects of dithiocarbamates onAP-l-containing and AP - 1 - less NFAT sites [J]. Eur J Immunol, 1999,29:1194 - 1201.
  • 7Angus D C,Linde -Zwirble W T,Lidicker J,et al. Epidemiology of severe sepsis in the United States:analysis of incidence,outcome, and associated costs of care [J].Crit Care Med,2001,29:1303 - 1310.
  • 8Arbour N C,Lorenz E,Schutte B C,et al.TLR4 mutations are associated with endotoxin hyporesponsiveness in human [J].Nat Genet,2000,25:187 - 191.
  • 9Oberholzer A,Oberholzer C,Moldawer L L, et al. Sepsis syndromes: understanding the role of innate and acquired immunity [J]. Shock,2001,16:83 - 96.
  • 10Pellegrini J D,De A K,Kodys K,et al.Relationships between T lymphocyte apoptosis and anergy following trauma [J]. J Surg Res, 2000,88: 200 - 206.

共引文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部